154 related articles for article (PubMed ID: 30796964)
21. The aromatic-L-amino acid decarboxylase inhibitor carbidopa is selectively cytotoxic to human pulmonary carcinoid and small cell lung carcinoma cells.
Gilbert JA; Frederick LM; Ames MM
Clin Cancer Res; 2000 Nov; 6(11):4365-72. PubMed ID: 11106255
[TBL] [Abstract][Full Text] [Related]
22. Opposite effects of glutamate antagonists and antiparkinsonian drugs on the activities of DOPA decarboxylase and 5-HTP decarboxylase in the rat brain.
Fisher A; Starr MS
Brain Res; 2000 Jun; 868(2):268-74. PubMed ID: 10854579
[TBL] [Abstract][Full Text] [Related]
23. Structural insight into Parkinson's disease treatment from drug-inhibited DOPA decarboxylase.
Burkhard P; Dominici P; Borri-Voltattorni C; Jansonius JN; Malashkevich VN
Nat Struct Biol; 2001 Nov; 8(11):963-7. PubMed ID: 11685243
[TBL] [Abstract][Full Text] [Related]
24. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.
Zhou JD; Shen F; Ji JS; Zheng K; Huang M; Wu JC
Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295
[TBL] [Abstract][Full Text] [Related]
25. Antisense oligonucleotides modulate dopa decarboxylase function in aromatic l-amino acid decarboxylase deficiency.
Tsai CR; Lee HF; Chi CS; Yang MT; Hsu CC
Hum Mutat; 2018 Dec; 39(12):2072-2082. PubMed ID: 30260058
[TBL] [Abstract][Full Text] [Related]
26. STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling.
Wang Z; Qu L; Deng B; Sun X; Wu S; Liao J; Fan J; Peng Z
Sci Rep; 2016 Sep; 6():33205. PubMed ID: 27628214
[TBL] [Abstract][Full Text] [Related]
27. Identification by virtual screening and in vitro testing of human DOPA decarboxylase inhibitors.
Daidone F; Montioli R; Paiardini A; Cellini B; Macchiarulo A; Giardina G; Bossa F; Borri Voltattorni C
PLoS One; 2012; 7(2):e31610. PubMed ID: 22384042
[TBL] [Abstract][Full Text] [Related]
28. Identification of novel alternative splice variants of the human L-DOPA decarboxylase (DDC) gene in human cancer cells, using high-throughput sequencing approaches.
Adamopoulos PG; Tsiakanikas P; Kontos CK; Panagiotou A; Vassilacopoulou D; Scorilas A
Gene; 2019 Nov; 719():144075. PubMed ID: 31449843
[TBL] [Abstract][Full Text] [Related]
29. Docetaxel promotes cell apoptosis and decreases SOX2 expression in CD133‑expressing hepatocellular carcinoma stem cells by suppressing the PI3K/AKT signaling pathway.
Zhang X; Shao J; Li X; Cui L; Tan Z
Oncol Rep; 2019 Feb; 41(2):1067-1074. PubMed ID: 30483804
[TBL] [Abstract][Full Text] [Related]
30. Association of Hepatitis C Virus Replication with the Catecholamine Biosynthetic Pathway.
Mpekoulis G; Tsopela V; Panos G; Siozos V; Kalliampakou KI; Frakolaki E; Sideris CD; Vassiliou AG; Sideris DC; Vassilacopoulou D; Vassilaki N
Viruses; 2021 Oct; 13(11):. PubMed ID: 34834946
[TBL] [Abstract][Full Text] [Related]
31. Expression of enzymatically active L-DOPA decarboxylase in human peripheral leukocytes.
Kokkinou I; Nikolouzou E; Hatzimanolis A; Fragoulis EG; Vassilacopoulou D
Blood Cells Mol Dis; 2009; 42(1):92-8. PubMed ID: 19041269
[TBL] [Abstract][Full Text] [Related]
32. MEL-pep, an analog of melittin, disrupts cell membranes and reverses 5-fluorouracil resistance in human hepatocellular carcinoma cells.
Ke M; Dong J; Wang Y; Zhang J; Zhang M; Wu Z; Lv Y; Wu R
Int J Biochem Cell Biol; 2018 Aug; 101():39-48. PubMed ID: 29800725
[TBL] [Abstract][Full Text] [Related]
33. Structural and functional analogies and differences between histidine decarboxylase and aromatic l-amino acid decarboxylase molecular networks: Biomedical implications.
Sanchez-Jiménez F; Pino-Ángeles A; Rodríguez-López R; Morales M; Urdiales JL
Pharmacol Res; 2016 Dec; 114():90-102. PubMed ID: 27769832
[TBL] [Abstract][Full Text] [Related]
34. Aromatic Amino Acid Decarboxylase Deficiency: The Added Value of Biochemistry.
Montioli R; Borri Voltattorni C
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808712
[TBL] [Abstract][Full Text] [Related]
35. Regulation of the Drosophila dopa decarboxylase gene in neuronal and glial cells.
Beall CJ; Hirsh J
Genes Dev; 1987 Jul; 1(5):510-20. PubMed ID: 3119425
[TBL] [Abstract][Full Text] [Related]
36. 3,4-dihydroxyphenylalanine (dopa) metabolism and retinoic acid induced differentiation in human neuroblastoma.
Ikeda H; Pastuszko A; Ikegaki N; Kennett RH; Wilson DF
Neurochem Res; 1994 Dec; 19(12):1487-94. PubMed ID: 7877718
[TBL] [Abstract][Full Text] [Related]
37. A kinetic analysis of Drosophila melanogaster dopa decarboxylase.
Black BC; Smarrelli J
Biochim Biophys Acta; 1986 Mar; 870(1):31-40. PubMed ID: 3081033
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of 5-methyl phenanthridium derivatives: a new class of human DOPA decarboxylase inhibitors.
Cheng P; Zhou J; Qing Z; Kang W; Liu S; Liu W; Xie H; Zeng J
Bioorg Med Chem Lett; 2014 Jun; 24(12):2712-6. PubMed ID: 24794108
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma.
Tu K; Liu Z; Yao B; Han S; Yang W
Int J Oncol; 2016 Mar; 48(3):965-74. PubMed ID: 26708293
[TBL] [Abstract][Full Text] [Related]
40. Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin.
Gazdar AF; Helman LJ; Israel MA; Russell EK; Linnoila RI; Mulshine JL; Schuller HM; Park JG
Cancer Res; 1988 Jul; 48(14):4078-82. PubMed ID: 3383200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]